US2005208547A1PendingUtilityA1
Oligonucleotide for detecting Salmonella and method of detecting Salmonella
Est. expiryJan 17, 2021(expired)· nominal 20-yr term from priority
C12Q 1/689Y02A50/30C12Q 1/6865
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides oligonucleotides for detecting Salmonella toxin gene invA mRNA and stn mRNA which oligonucleotides specifically bind to invA mRNA or stn mRNA at a relatively low temperature (for example, 41° C.) and at a constant temperature, and a process of amplifying Salmonella toxin gene invA mRNA or stn mRNA and a method of detecting the same using the oligonucleotides.
Claims
exact text as granted — not AI-modified1 - 3 . (canceled)
4 . A process of amplifying Salmonella gene stn mRNA having a specific sequence, comprising
obtaining a sample comprising Salmonella gene stn mRNA synthesizing cDNA employing an RNA-dependent DNA polymerase resulting in an RNA/DNA hybrid, digesting the RNA of the RNA/DNA hybrid with Ribonuclease H to produce a single-stranded DNA, producing a double-stranded DNA having a promoter sequence capable of transcribing RNA comprising said specific sequence or a sequence complementary to said specific sequence employing a DNA-dependent DNA polymerase, wherein said single-stranded DNA is the template for said producing and wherein said double-stranded DNA produces an RNA transcription product in the presence of an RNA polymerase, and synthesizing cDNA comprising annealing an oligonucleotide primer pair consisting of (a) a sequence selected from the group consisting of SEQ ID NOs: 13 to 18 and (b) a sequence selected from the group consisting of SEQ ID NOs: 24 to 27 to said RNA transcription product and amplifying said cDNA by employing said RNA-dependent DNA polymerase, where either primer includes an RNA polymerase promoter sequence at the 5′ end.
5 . The process according to claim 4 , which is a detection method, wherein said amplifying is performed in the presence of an oligonucleotide probe which has a sequence that is complementary to at least a portion of the RNA transcription product, is labeled with an intercalator fluorescent pigment, and has a sequence different from said oligonucleotide primer pair, wherein changes in the fluorescent properties of the intercalator are measured.
6 . The detection method according to claim 5 , wherein said probe is designed so as to complementarily bind to at least a portion of the sequence of said RNA transcription product, and the fluorescent property changes relative to that of a situation where a complex formation is absent.
7 . (canceled)
8 . The detection method according to claim 6 , wherein said probe for detecting said stn mRNA comprises at least 10 contiguous bases of SEQ. ID. No. 29 or its complementary sequence.
9 . The process of claim 4 , wherein said annealing is at a temperature ranging from 35 to 50° C.
10 . The process of claim 4 , wherein said amplifying said cDNA is at a temperature ranging from 35 to 50° C.
11 . The process of claim 10 , wherein said amplifying said cDNA is at a constant temperature.
12 . The process of claim 4 , wherein the process is performed by employing a single enzyme having RNA-dependent DNA polymerase activity, DNA-dependent DNA-polymerase activity, and ribonuclease H activity.
13 . The process of claim 12 , wherein said enzyme is AMV reverse transcriptase.
14 . The process of claim 4 , wherein said RNA polymerase is a T7 phage RNA polymerase or a SP6 phage RNA polymerase.
15 . The process of claim 4 , wherein said sequence selected from the group consisting of SEQ ID NOs: 13 to 18 is the sequence of SEQ ID NO: 15.
16 . The process of claim 4 , wherein said sequence selected from the group consisting of SEQ ID NOs: 24 to 27 is the sequence of SEQ ID NO: 25.
17 . The detection method according to claim 5 , wherein said intercalator fluorescent pigment is bonded to a phosphorus atom in the oligonucleotide probe through a linker.
18 . The detection method according to claim 5 , wherein said oligonucleotide probe is modified at the 3′ hydroxyl group such that extension from said probe is inhibited.
19 . The detection method according to claim 18 , wherein said oligonucleotide probe is modified at the 3′ hydroxyl group by addition of a glycolic acid.
20 . The detection method according to claim 5 , wherein said sequence selected from the group consisting of SEQ ID NOs: 13 to 18 is the sequence of SEQ ID NO: 15.
21 . detection method according to claim 5 , wherein said sequence selected from the group consisting of SEQ ID NOs: 24 to 27 is the sequence of SEQ ID NO: 25.
22 . The detection method according to claim 8 , wherein said oligonucleotide probe is modified at the 3′ hydroxyl group such that extension from said probe is inhibited.
23 . The detection method according to claim 22 , wherein said oligonucleotide probe is modified at the 3′ hydroxyl group by addition of a glycolic acid.Join the waitlist — get patent alerts
Track US2005208547A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.